Author

Francesco Benanti

Observed names: F Benanti, F. Benanti

Institutions: University of Catania, Ospedale Garibaldi

Observed institutions: University of Catania, Ospedale Garibaldi

OpenAlex ID: A5014375166

Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents

2018 · Vincenza Calvaruso, Giuseppe Cabibbo, et al. · Gastroenterology · 372

Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients

2019 · Giuseppe Cabibbo, Ciro Celsa, et al. · Journal of Hepatology · 208

Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct‐acting antivirals? A prospective multicentre study

2017 · G. Cabibbo, S. Petta, et al. · Alimentary Pharmacology & Therapeutics · 148

PDF

Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas

2018 · Michele Merli, Marco Frigeni, et al. · The Oncologist · 71

PDF

Acute hepatitis E in catania (eastern sicily) 1980–1994. The role of hepatitis E virus

1997 · B. Cacopardo, R. Russo, et al. · Infection · 56

Immunological and Clinical Impact of DAA-Mediated HCV Eradication in a Cohort of HIV/HCV Coinfected Patients: Monocentric Italian Experience

2021 · Andrea Marino, Gabriella Zafarana, et al. · Diagnostics · 28

PDF

Clinical characteristics and predictors of death among hospitalized patients infected with SARS‑CoV‑2 in Sicily, Italy: A retrospective observational study

2022 · Federica Cosentino, Vittoria Moscatt, et al. · Biomedical Reports · 26

PDF

Rheumatoid arthritis following PEG-interferon-alfa-2a plus ribavirin treatment for chronic hepatitis C: a case report and review of the literature

2013 · Bruno Cacopardo, Francesco Benanti, et al. · BMC Research Notes · 26

PDF

Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST‐HCV cohort

2021 · Vincenza Calvaruso, Salvatore Petta, et al. · Journal of Viral Hepatitis · 24

PDF

Trimethoprim-sulfamethoxazole-associated severe hypoglycaemia: a sulfonylurea-like effect.

2010 · G Nunnari, B M Celesia, et al. · PubMed · 23

Leucocyte interferon‐α retreatment for chronic hepatitis C patients previously intolerant to other interferons

1998 · B. Cacopardo, F. Benanti, et al. · Journal of Viral Hepatitis · 23

Entecavir resistance in a patient with treatment‑naïve HBV: A case report

2021 · Andrea Marino, Federica Cosentino, et al. · Molecular and Clinical Oncology · 21

PDF

Fatal hepatitis during Epstein-Barr virus reactivation.

2003 · B Cacopardo, G Nunnari, et al. · PubMed · 19

Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients

2019 · G. Cabibbo, C. Celsa, et al. · Digestive and Liver Disease · 15

Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study

2025 · Luca Rinaldi, Mauro Viganò, et al. · Viruses · 12

PDF

Cirrhotic patients are still at risk of developing hepatocellular carcinoma despite Interferon-induced sustained virological response.

2014 · M R Pinzone, A M Zanghì, et al. · PubMed · 12

Modification of Serum Brain-Derived Neurotrophic Factor Levels Following Anti-HCV Therapy with Direct Antiviral Agents: A New Marker of Neurocognitive Disorders

2020 · Andrea Marino, Daniele Scuderi, et al. · Hepatitis Monthly · 8

Factors Enhancing Treatment of Hepatitis C Virus–Infected Italian People Who Use Drugs: The CLEO-GRECAS Experience

2021 · Luca Rinaldi, Vincenzo Messina, et al. · The American Journal of Gastroenterology · 5

Risk of hepatocellular carcinoma (HCC) recurrence in HCV cirrhotic patients treated with Direct Acting Antivirals (DAAs)

2017 · G. Cabibbo, I. Cacciola, et al. · Digestive and Liver Disease · 3

Leukocyte Interferon Alpha Early Retreatment for Child A HCV Genotype 1b-Infected Cirrhotics Intolerant to Pegylated Interferons

2008 · B. Cacopardo, G. Nunnari, et al. · Infection · 3

Efficacy of oral direct acting antivirals for treatment of advanced chronic hepatitis or compensated cirrhosis due to hepatitis C virus infection: The real-life experience of the Sicily registry

2017 · I. Cacciola, S. Petta, et al. · Digestive and Liver Disease · 2

[Long-term study of anti-HCV reactivity using 3d generation recombinant immunoblot assay in acute post-transfusion hepatitis].

1995 · B Cacopardo, F Fatuzzo, et al. · PubMed · 1

WED-303 Assessment of response and impact of safety treatment with bulevirtide in patients with chronic delta virus infection: an observational trial for evaluating long-term efficacy. The ARISTOTELE study

2025 · Luca Rinaldi, Mauro Viganò, et al. · Journal of Hepatology

Assessment of response and impact of safety treatment with bulevirtide in patients with chronic delta virus infection: an observational trial for evaluating long-term efficacy. the ARISTOTELE pilot study

2025 · L. Rinaldi, M. Viganò, et al. · Digestive and Liver Disease

Efficacy and safety of pangenotypic DAAs for chronic HCV infection: real-world data from the RESIST-HCV cohort

2022 · F. Salomone, I. Cacciola, et al. · Digestive and Liver Disease

Works count: 35

Citation count: 1,478

H-index: 15

I10-index: 17